Iteos Therapeutics Inc (ITOS)
Iteos Therapeutics Inc (ITOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Sales | 53,905 | 19,487 | 41,716 | 152,522 | 240,504 |
| Gross Profit | 53,905 | 19,487 | 41,716 | 152,522 | 240,504 |
| Operating Expenses | 36,522 | 34,692 | 38,381 | 31,711 | 26,983 |
| Operating Income | 17,383 | -15,205 | 3,335 | 120,811 | 213,521 |
| Other Income | 5,363 | 13,219 | 5,108 | -1,278 | 10,523 |
| Pre-tax Income | 22,746 | -1,986 | 8,443 | 119,533 | 224,044 |
| Income Tax | 2,293 | -2,977 | 2,817 | 49,951 | 39,172 |
| Net Income Continuous | 20,453 | 991 | 5,626 | 69,582 | 184,872 |
| Net Income | $20,453 | $991 | $5,626 | $69,582 | $184,872 |
| EPS Basic Total Ops | 0.57 | 0.03 | 0.16 | 1.96 | 5.26 |
| EPS Basic Continuous Ops | 0.57 | 0.03 | 0.16 | 1.96 | 5.26 |
| EPS Diluted Total Ops | 0.56 | 0.03 | 0.15 | 1.82 | 4.96 |
| EPS Diluted Continuous Ops | 0.56 | 0.03 | 0.15 | 1.82 | 4.96 |
| EBITDA(a) | $15,878 | $-15,000 | $3,530 | $120,991 | $213,672 |